<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/10C7A2C0-31BF-432E-9B48-84E1067D233D"><gtr:id>10C7A2C0-31BF-432E-9B48-84E1067D233D</gtr:id><gtr:firstName>Scott</gtr:firstName><gtr:surname>Levison</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800456"><gtr:id>883358DD-371B-495A-BEA4-DF1BA31D9D48</gtr:id><gtr:title>Genetic dissection of immunity and inflammation in a model of Crohn's colitis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800456</gtr:grantReference><gtr:abstractText>Crohn?s disease causes abdominal pain, diarrhoea, bleeding, weight loss and under-nutrition. Patients require long-term medication and many need surgery. Understanding disease mechanisms is vital for therapeutic advances. What is not fundamentally understood is why some people are more susceptible than others to chronic intestinal inflammation. However, there is a strong genetic component. 

I will induce colonic inflammation in two mouse strains using Trichuris muris, a nematode infection. These strains have polarised outcomes. One (AKR) develops chronic colonic inflammation, the other (BALB/c) only transient inflammation then rapid resolution. We have identified five chromosomal regions associated with these responses. Interestingly, these mouse gene clusters correspond to human gene clusters known to be important in Crohn?s. 

I will identify more precisely the genes differing between strains, in order to discover which contribute to the different inflammatory outcomes. I will analyse tissue responses in susceptible mice with chronic inflammation, comparing this to resistant mice making a full recovery. I will drill down to the specific genetic differences between the 2 strains, and begin to translate my findings into human disease, using colonic tissue and DNA. 

Since these mechanisms are unlikely to be organ-specific my research may have broader relevance for inflammation outside the gut.</gtr:abstractText><gtr:technicalSummary>Trichuris muris colitis represents an advanced and tractable murine model for understanding the pathobiological mechanisms of chronic colitis. The key facet of the model is that despite identical injury some inbred mouse strains develop chronic colitis whilst others recover, quickly and fully. A recently completed Quantitative Trait Locus (QTL) study, performed by crossbreeding a resistant with a susceptible strain, identified five chromosomal loci linked to chronic colitis. Pivotally, these QTL?s demonstrate significant orthology to human chromosomal loci linked to Crohn?s disease.

Aims:
To characterise the functional genetic differences between mouse strains susceptible or resistant to developing chronic colonic inflammation and begin to translate my findings into clinical studies.

Objectives:
 To analyse differential gene expression by comparing tissue from susceptible and resistant T.muris infected mice. 
 To take a Bioinformatics approach to profile expression patterns and thereby identify pathways of functionally important and mechanistically connected genes. This is in order to identify the leading candidates for determining outcome.
 To further prioritise and enhance differentially expressed genes, by cross-referencing my new expression data to our existing QTL data.
 To identify strain-specific genetic sequence polymorphisms in differentially expressed QTL genes.
 To begin to translate this knowledge into studies of human chronic colitis.

Methodology:
Mouse: Susceptible (AKR) and resistant (BALBc) strains will be infected with T.muris. Na&amp;iuml;ve animals will be compared to early infected and chronically inflamed/resolved time-points. Immune responses, colonic histology and worm count, will be assessed. Colonic and mesenteric lymph node mRNA will undergo Affymetrix expression analysis. A bioinformatics approach will then identify both functionally (eg immunological pathways) and positionally associated genes. Genomic DNA sequencing will idencandidate gene polymorphisms differing between strains.
Human: Colonic biopsies from healthy controls and Crohn?s patients (affected and unaffected bowel) are currently being harvested. Emergent murine candidate genes will be studied at mRNA, protein and tissue levels. A DNA sample from 800 local IBD patients and &amp;gt;2000 healthy controls has already been banked for necessary human genetic studies.

Scientific/Medical Opportunities:
The polarised difference in outcome between the 2 inbred mice strains presents a new paradigm for identifying biological factors which permit or prevent chronic colonic inflammation developing. Furthermore, susceptible mice are prone to other inflammatory disorders so my discoveries may have significance beyond the colon. Greater knowledge of disease pathogenesis and of intrinsic mechanisms leading to early resolution of inflammation will ultimately help to develop new therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>202283</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Museum of Manchester Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>1B43C1ED-6BF5-427B-A8BF-956359977C36</gtr:id><gtr:impact>Science weeks &amp;quot;Body Experience&amp;quot; at the niversity of manchester.

I was a member of the &amp;quot;Gut&amp;quot; stand

Good fun for the visitors and staff for the weekend</gtr:impact><gtr:outcomeId>jj3e3Zt8K9u</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E2CCEB41-249B-4358-A5B9-C82B6638AFC6</gtr:id><gtr:impact>Part of the Manchester Immunology Research Group visit for schools

Good interaction and contributions from secondary school children</gtr:impact><gtr:outcomeId>H658Ef188ZH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Festschrift - Dundee</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E9620ADE-A52D-4D11-AFB0-97A04807E010</gtr:id><gtr:impact>Lecture introducing my research and initial phenotypic and expression data.

General interest and questions.</gtr:impact><gtr:outcomeId>D82A5BACDA2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1B5E2198-7A0A-4990-BB3F-BFA08DD7233C</gtr:id><gtr:title>S1739 Interleukin-23/TH17 Pathway Expression in Chronic Trichuris Muris Colitis: Lessons for Iatrogenic Helminthosis</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf1137d7dae8b4e8bf4dac0cbdf32e4"><gtr:id>dbf1137d7dae8b4e8bf4dac0cbdf32e4</gtr:id><gtr:otherNames>Levison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>PR5Hh4KNF4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0434774-33C2-41D7-B9B9-349DB1A3E180</gtr:id><gtr:title>OC-010 Phenotyping
 
 colitis reveals innate and adaptive immunological commonalities to human Crohn's disease</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf1137d7dae8b4e8bf4dac0cbdf32e4"><gtr:id>dbf1137d7dae8b4e8bf4dac0cbdf32e4</gtr:id><gtr:otherNames>Levison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>T2DpW7SwwdR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4553F3C6-B400-48BE-AAA6-A3A12636503F</gtr:id><gtr:title>Anti-TNFa antibodiy therapy alters effector and regulatory phenotype in experimental colitis.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9b50117b0db3a233e4d8937c9cd7c6d"><gtr:id>e9b50117b0db3a233e4d8937c9cd7c6d</gtr:id><gtr:otherNames>Levison SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>mUHQs7BmQ8c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>669E16EE-6B0F-4F56-AF4A-B35EC4089038</gtr:id><gtr:title>Genetic susceptibility to chronic trichuris muris induced experimental colitis: translation and relevance to human Crohn's disease</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbf1137d7dae8b4e8bf4dac0cbdf32e4"><gtr:id>dbf1137d7dae8b4e8bf4dac0cbdf32e4</gtr:id><gtr:otherNames>Levison S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>EikyAnEKKrx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>749639B7-0A10-4007-9D5C-AFC53606DB2C</gtr:id><gtr:title>Genotype-Phenotype Correlation, Colonic Transcription and Functional Analysis Implicate Vav3 in Colitis</gtr:title><gtr:parentPublicationTitle>GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a7b06527ab54270d67bfb9a5c4dc731"><gtr:id>9a7b06527ab54270d67bfb9a5c4dc731</gtr:id><gtr:otherNames>Levison Scott E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>j8sVZgo9Pyp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8FF5BD4-9C0B-4C97-8C3B-CDD9AC4687A1</gtr:id><gtr:title>ANTI-TNF alpha ANTIBODY THERAPY AND PARENTERAL CORTICOSTEROIDS DEMONSTRATE DISTINCT EFFECTS IN THE TREATMENT OF EXPERIMENTAL TRICHURIS MURIS-INDUCED CHRONIC COLITIS</gtr:title><gtr:parentPublicationTitle>GUT</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e962e3b2353f2db094f251b28417dbd"><gtr:id>5e962e3b2353f2db094f251b28417dbd</gtr:id><gtr:otherNames>Levison S. E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>gomoo5n9FgV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A89C9F8-566D-4459-83FF-D41A7A2B8C68</gtr:id><gtr:title>Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor a neutralization.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2d571dfccdc5028275f4b6a4f186064"><gtr:id>c2d571dfccdc5028275f4b6a4f186064</gtr:id><gtr:otherNames>Assas BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>5a2fd277728d11.64617320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B04BE7B4-B4FD-4153-8D82-ACEDD7430B26</gtr:id><gtr:title>Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9b50117b0db3a233e4d8937c9cd7c6d"><gtr:id>e9b50117b0db3a233e4d8937c9cd7c6d</gtr:id><gtr:otherNames>Levison SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>sodmUf6QaeB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FD71989-4A38-4610-9C7D-9D25F1994899</gtr:id><gtr:title>Generic lessons for chronic colitis: whole-transcript expression analysis in Trichuris muris colitis</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9b50117b0db3a233e4d8937c9cd7c6d"><gtr:id>e9b50117b0db3a233e4d8937c9cd7c6d</gtr:id><gtr:otherNames>Levison SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>C335A4324B9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800456</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>